Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.36 +0.04 (1.72%)
Previous Close $2.32    52 Week High $4.76 
Open $2.33    52 Week Low $1.46 
Day High $2.43    P/E N/A 
Day Low $2.26    EPS $-1.91 
Volume 1,075,503